Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports
The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk’s Wegovy.
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
usnews Feb 29, 2024 0 288
usnews Jul 4, 2024 0 283
usnews Jul 4, 2024 0 273
usnews Jul 4, 2024 0 267
usnews Jul 4, 2024 0 264